Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

10.7%

3 terminated/withdrawn out of 28 trials

Success Rate

81.3%

-5.3% vs industry average

Late-Stage Pipeline

4%

1 trials in Phase 3/4

Results Transparency

15%

2 of 13 completed trials have results

Key Signals

3 recruiting2 with results

Enrollment Performance

Analytics

N/A
12(66.7%)
Phase 2
3(16.7%)
Early Phase 1
1(5.6%)
Phase 1
1(5.6%)
Phase 3
1(5.6%)
18Total
N/A(12)
Phase 2(3)
Early Phase 1(1)
Phase 1(1)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (28)

Showing 20 of 28 trials
NCT05825105Phase 2Active Not Recruiting

Effectiveness of Platelet-rich Plasma Treatment of Knee Osteoarthritis

Role: collaborator

NCT05372445Not ApplicableTerminated

Microbiome and Health Indicators in People With Obesity, Prediabetes and Type 2 Diabetes Undergoing a Lifestyle Intervention

Role: lead

NCT07304349Recruiting

Prospective Evaluation of Rapid Diagnostic Tests for Trypanosoma Cruzi Infection

Role: collaborator

NCT06748976Recruiting

Modulation of Cortical Brain Activity During Attentional Control

Role: lead

NCT06905171Completed

Habituation of Brain Responses to Sensory Stimuli in Fibromyalgia

Role: lead

NCT05910372Completed

Tools for the Differential Diagnosis of Fibromyalgia Based on Cognitive Tasks

Role: lead

NCT06183593Not ApplicableCompleted

Accuracy in the Evaluation of Brain Response to Mechanical and Radiofrequency Stimuli in Humans

Role: lead

NCT06532903Not ApplicableRecruiting

Functional Recovery From Facial Paralysis

Role: collaborator

NCT05752201Phase 2Completed

ARVAC-A New Recombinant Coronavirus Disease 2019 (COVID-19) Vaccine

Role: collaborator

NCT05656508Phase 1Completed

ARVAC - A New Recombinant Coronavirus Disease 2019 (COVID-19) Vaccine

Role: collaborator

NCT05160220Not ApplicableCompleted

Naturalistic Study of Microdosing With Psilocybin

Role: lead

NCT05118594Not ApplicableNot Yet Recruiting

Testing a Precision Psychotherapy System for Low-income Patients

Role: lead

NCT03278639Not ApplicableWithdrawn

Efficacy and Safety or Rhythmic Auditory Stimulation (RAS) for Gait and Balance Disorders in Parkinson's Disease

Role: collaborator

NCT03303755Completed

Predictive Models of Weight and Height for the Evaluation of the Growth of Children and Adolescents With Cerebral Palsy

Role: lead

NCT04179422Unknown

Nutritional Status and Family Strategies in Children With Cerebral Palsy.

Role: lead

NCT04773808Unknown

Molecular Characterization of Genetic Alterations in Pediatric Solid Tumors

Role: lead

NCT02095561Not ApplicableCompleted

Evaluation of Human Papilloma Virus (HPV) Self-testing to Increase Screening Uptake

Role: collaborator

NCT04382768Not ApplicableUnknown

Inhaled Ibuprofen to Treat COVID-19

Role: collaborator

NCT03338777Early Phase 1Terminated

Suicide Plus Immune Gene Therapy for Advanced Melanoma

Role: collaborator

NCT04177017Not ApplicableCompleted

Mindfulness, Empathy and Social Integration. Its Relation With Chonic Stress

Role: lead